Better Buy: UnitedHealth Group Inc. Vs. Humana

Both United and Humana are leveraging enrollment growth for upside, but Humana may be the better buy.

Feb 28, 2014 at 2:30PM

Looking beyond media sound bites and Washington infighting has rewarded UnitedHealth Group (NYSE:UNH) and Humana (NYSE:HUM)investors. There's no question the two operate in a highly competitive market where margin is thin and regulations are continuously changing. However, launching products like Medicare Advantage that boost membership and drive revenue higher allow the industry to endure -- and even thrive -- amid change.

As a result, shares in both United and Humana have climbed from around $20 in 2009 to $75 and $112, respectively -- making it a good time to consider if one is a better buy than the other.

UNH Chart

UNH data by YCharts

Addressing more needs
Since being reworked in 2003, Medicare Advantage has been a growing source of revenue for both companies. These insurance plans are offered to seniors as a substitute for traditional Medicare. Specifically, Medicare Advantage plans provide more comprehensive Part A and Part B care than traditional Medicare, which means potentially better inpatient and outpatient coverage.

Since claims are processed through the insurer and then reimbursed by Medicare, the companies can boost profit by leveraging existing networks, eliminating wasteful spending, and lowering patient utilization of high cost care. 

This focus on containing costs has been keeping operating margin in check at both companies. At United, it has been ranging between seven percent and eight percent, and at Humana operating margin has been between four and six percent over the last five years.

As revenue is climbing, stable margin is allowing more money to drop to earnings. Trailing 12 month earnings per share has grown from less than $3 in 2009 to nearly $5.50 at United, and it has grown from less than $5 in 2009 to $7.70 per share at Humana. That cost consciousness will come in handy given Medicare is lowering its reimbursement rates this year.

UNH EPS Diluted (TTM) Chart

UNH EPS Diluted (TTM) data by YCharts

Adjusting to new opportunity
Even though earnings are growing, concerns tied to Obamacare remain. Many of the first to sign up on exchanges may have been previously uninsured due to pre-existing conditions. As those enrollees begin filing claims, insurers may feel the pinch.

Another challenge facing United and Humana is the drop in Medicare Advantage reimbursement rates. Last fall, United warned those headwinds would weigh on profit this year, prompting management to issue earnings guidance of $5.40 to $5.60 per share for 2014 -- roughly in line with results in 2013. 

That pessimism has led to analysts lowering their estimates for this year, and for next year too. In the past three months, analysts have cut their 2015 EPS outlook for United from $6.29 to $6.11. Since Medicare products represent an even bigger share of Humana's revenue, the headwinds should create a similar drag on its results. Humana is guiding for earnings of $7.25 to $7.75 in 2014, which suggests that earnings may come in below the $7.73 Humana earned in 2013. 

Despite the potential pause in earnings this year, analysts think Humana's bottom line will accelerate in 2015. In contrast to United, estimates for 2015 have climbed from $8.45 to $8.68 over the past 90 days for Humana.

Debating valuation
Investors may argue that United's diversified product line deserves a premium valuation, and current valuation metrics seem to bear that out. Investors are currently paying 12.4 times next year earnings for United's shares, that's above the company's five year average P/E ratio of 10. United also comes with a higher price to book, price to sales, and price to growth ratio than Humana.

That's not to say Humana is cheap. Investors are paying 12.6 times forward earnings for its shares too, and that's also above its average five year level of 9. However, given United's ratios are higher across other valuation metrics, an argument could be made that the benefit of United's diversity is currently reflected in its share price; at least relative to Humana.

If that's the case, United will need to over-deliver on earnings to justify a significantly higher price. If exchange driven private insurance enrollment for less costly, young people ends up being back-end loaded, the economy boosts group enrollment, and Medicare Advantage enrollment accelerates, then United has a good chance of outpacing those lowered expectations.

Humana may prove an even better bargain given its lower valuation metrics, especially since the company is so heavily tilted toward Medicare. Since 10,000 baby boomers are turning 65 every day, there's plenty of opportunity for Medicare Advantage enrollment growth. Importantly, Medicare Advantage cuts for 2015 look to be closer to 4% than the 7% previously feared, suggesting analysts may adjust earnings projections for Humana higher, not lower.

Fool-worthy final thoughts
Both companies have opportunities to move higher if cost containment can outpace the risk of higher utilization and lower reimbursement. But its not just Medicare that offers these two an opportunity for growth. The two also benefit from Medicaid. 

United pulled in more than $18 billion last year from Medicaid products, up 11% from 2012. And Humana's Medicaid membership grew 64% last year thanks to new products in Kentucky and Florida. Since Medicaid enrollment is increasing thanks to Obamacare, sales from related products should improve this year too. 

Fools should keep a close eye on quarterly enrollment growth and operating margin the next couple quarters to see if these companies are outpacing forecasts. Investors should also pay close attention to April 7th, because that's when Medicare releases its final reimbursement rates for Advantage plans. If final cuts are closer to 7%, Humana will likely suffer more than United; however, if rate cuts are less, Humana may benefit.

The stock market's biggest potential Obamacare winners
Obamacare seems complex, but it doesn't have to be. In only minutes, you can learn the critical facts you need to know in a special free report called "Everything You Need to Know About Obamacare." This FREE guide contains the key information and money-making advice that every American must know. Please click here to access your free copy.


Todd Campbell has no position in any stocks mentioned. Todd owns E.B. Capital Markets, LLC. E.B. Capital's clients may or may not have positions in the companies mentioned. Todd owns Gundalow Advisor's, LLC. Gundalow's clients do not have positions in the companies mentioned. The Motley Fool recommends UnitedHealth Group. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

1 Key Step to Get Rich

Our mission at The Motley Fool is to help the world invest better. Whether that’s helping people overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we can help.

Feb 1, 2016 at 4:54PM

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The Motley Fool as the #1 place online to get smarter about investing.

"The Motley Fool aims to build a strong investment community, which it does by providing a variety of resources: the website, books, a newspaper column, a radio [show], and [newsletters]," wrote (the clearly insightful and talented) money reporter Kathleen Elkins. "This site has something for every type of investor, from basic lessons for beginners to investing commentary on mutual funds, stock sectors, and value for the more advanced."

Our mission at The Motley Fool is to help the world invest better, so it's nice to receive that kind of recognition. It lets us know we're doing our job.

Whether that's helping the entirely uninitiated overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we want to provide our readers with a boost to the next step on their journey to financial independence.

Articles and beyond

As Business Insider wrote, there are a number of resources available from the Fool for investors of all levels and styles.

In addition to the dozens of free articles we publish every day on our website, I want to highlight two must-see spots in your tour of

For the beginning investor

Investing can seem like a Big Deal to those who have yet to buy their first stock. Many investment professionals try to infuse the conversation with jargon in order to deter individual investors from tackling it on their own (and to justify their often sky-high fees).

But the individual investor can beat the market. The real secret to investing is that it doesn't take tons of money, endless hours, or super-secret formulas that only experts possess.

That's why we created a best-selling guide that walks investors-to-be through everything they need to know to get started. And because we're so dedicated to our mission, we've made that available for free.

If you're just starting out (or want to help out someone who is), go to, drop in your email address, and you'll be able to instantly access the quick-read guide ... for free.

For the listener

Whether it's on the stationary exercise bike or during my daily commute, I spend a lot of time going nowhere. But I've found a way to make that time benefit me.

The Motley Fool offers five podcasts that I refer to as "binge-worthy financial information."

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. It's also featured on several dozen radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable ... and I don't say that simply because the hosts all sit within a Nerf-gun shot of my desk. Rule Breaker Investing and Answers contain timeless advice, so you might want to go back to the beginning with those. The other three take their cues from the market, so you'll want to listen to the most recent first. All are available at

But wait, there's more

The book and the podcasts – both free ... both awesome – also come with an ongoing benefit. If you download the book, or if you enter your email address in the magical box at the podcasts page, you'll get ongoing market coverage sent straight to your inbox.

Investor Insights is valuable and enjoyable coverage of everything from macroeconomic events to investing strategies to our analyst's travels around the world to find the next big thing. Also free.

Get the book. Listen to a podcast. Sign up for Investor Insights. I'm not saying that any of those things will make you rich ... but Business Insider seems to think so.

Compare Brokers